Pharming Group N.V. Files Form 6-K with Press Release
Ticker: PHAR · Form: 6-K · Filed: Apr 25, 2025 · CIK: 1828316
| Field | Detail |
|---|---|
| Company | Pharming Group N.V. (PHAR) |
| Form Type | 6-K |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, press-release
TL;DR
Pharming Group N.V. dropped a 6-K filing with a press release on 4/25/25 - check it for news.
AI Summary
Pharming Group N.V. announced on April 25, 2025, that it is furnishing a press release as Exhibit 99.1 to its Form 6-K filing. The press release details are not provided in this filing, but it is related to the company's operations for the month of April 2025.
Why It Matters
This filing indicates that Pharming Group N.V. is providing updated information to the SEC, which could contain material developments relevant to investors.
Risk Assessment
Risk Level: low — This filing is a routine submission of a press release and does not contain specific financial results or significant operational changes that would inherently increase risk.
Key Players & Entities
- Pharming Group N.V. (company) — Registrant
- April 25, 2025 (date) — Filing and press release date
- 001-39822 (other) — SEC File Number
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to furnish a press release dated April 25, 2025, as Exhibit 99.1.
What is the exact name of the registrant?
The exact name of the registrant is Pharming Group N.V.
What is the SEC file number for Pharming Group N.V.?
The SEC file number for Pharming Group N.V. is 001-39822.
On what date was the press release furnished to the SEC?
The press release was furnished to the SEC on April 25, 2025.
Does Pharming Group N.V. file annual reports under Form 20-F or 40-F?
Pharming Group N.V. files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 25, 2025 regarding Pharming Group N.V. (PHAR).